Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome
By B. Bart, S. Goldsmith, Kerry L Lee, M. Givertz, C. O'connor, D. Bull, M. Redfield, A. Deswal, J. Rouleau, M. LeWinter and 12 more. New England Journal of Medicine, 2012
906 citations recorded by the source corpus.
BACKGROUND Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of patients with acute decompensated heart failure. Little is known about the efficacy and safety of ultrafiltration in patients with acute decompensated heart failure complicated by persistent congestion and worsened renal function. METHODS We randomly assigned a total of 188 patients with acute decompensated heart failure, worsened renal function, and persistent congestion to a strategy of stepped pharmacologic therapy (94 patients) or ultrafiltration (94 patients). The primary end point was the bivariate change from baseline in the serum creatinine level and body weight, as assessed 96 hours after random assignment. Patients were followed for 60 days. RESULTS Ultrafiltration was inferior to pharmacologic therapy with respect to the bivariate end point of the change in the serum creatinine level and body weight 96 hours after enrollment (P=0.003), owing primarily to an increase in the creatinine level in the ultrafiltration group. At 96 hours, the mean change in the creatinine level was −0.04±0.53 mg per deciliter (−3.5±46.9 μmol per liter) in the pharmacologic-therapy group, as compared with +0.23±0.70 mg per deciliter (20.3±61.9 μmol per liter) in the ultrafiltration group (P=0.003). There was no significant difference in weight loss 96 hours after enrollment between patients in the pharmacologic-therapy group and those in the ultrafiltration group (a loss of 5.5±5.1 kg [12.1±11.3 lb] and 5.7±3.9 kg [12.6±8.5 lb], respectively; P=0.58). A higher percentage of patients in the ultrafiltration group than in the pharmacologic-therapy group had a serious adverse event (72% vs. 57%, P=0.03). CONCLUSIONS In a randomized trial involving patients hospitalized for acute decompensated heart failure, worsened renal function, and persistent congestion, the use of a stepped pharmacologic-therapy algorithm was superior to a strategy of ultrafiltration for the preservation of renal function at 96 hours, with a similar amount of weight loss with the two approaches. Ultrafiltration was associated with a higher rate of adverse events.
Subfields: Cardiology and Cardiovascular Medicine, Hematology, Nephrology
View Paper: https://www.semanticscholar.org/paper/46ff3ea3c277d768f816154469d3f68cdde9a436
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- V. Harjola
- J. Parissis
- B. Pieske
- E. Jankowska
- Héctor Bueno
- J. González-Juanatey
- Andrew J.S. Coats
- P. Ponikowski
Citations in the corpus
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, positive): “Since the sensitivity and specificity of symptoms and signs are often not satisfactory, careful clinical evaluation needs to be followed by these additional investigations: † Chest X-ray can be a useful test for the diagnosis of AHF.”